ClinicalTrials.gg
RecruitingNCT05995886Updated Nov 19, 2026

Using Facebook to Support Opioid Recovery Among American Indian Women

An interventional study of Wiidookaage'win Facebook Group in Opioid Use Disorder, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.
Updated Nov 19, 2026Study completion movedPrimary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,223 studies in Opioid-Related Disorders with a site in United States — 246 open to participants now, 316 under way, 18 of them phase 3. Opioid-Related Disorders · United States.

Planned enrollment
513th of 1,098
60 · median 56
Started
2023
with 83 others
No phase
571 of 1,223
133 open now
Primary completion
2026-10
later than 67 of 315 live
Registered
943rd of 1,223
by date

Among the 1,223 studies in Opioid-Related Disorders with a site in United States, this one is the 513th largest by planned enrollment of the 1,098 interventional ones that give a count, is one of 84 that started in 2023, is one of 571 with no phase, reaches primary completion later than 67 of the 315 other live ones, and was the 943rd registered.

Opioid-Related Disorders

1,476 studies on the registry are indexed under Opioid-Related Disorders; 293 are open to participants now.

Browse Opioid-Related Disorders studies →

Open to participants now

246 of the 1,223 studies in Opioid-Related Disorders with a site in United States are open now. Recruiting first, the newest first:

241 more — sign in →

All 246 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 213 Opioid-Related Disorders studies recruiting now, 123 (58%) set no upper age limit and 76 (36%) stop at 75 or younger; 14 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,223 studies in Opioid-Related Disorders with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

03

Conditions studied

  • Opioid Use Disorder

Keywords

  • American Indian or Alaska Native
  • Internet-based Intervention
  • Community-based Participatory Research
  • Minnesota
  • Ethnic and Racial Minorities
  • Women's Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. AIAN person based on self-reported race/ethnicity
  2. Gender identity as a woman
  3. At least 18 years of age with no upper age limit
  4. Resides in Minnesota
  5. Meets criteria for OUD based on the Checklist (American Psychiatric Association, 2013)
  6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen
  7. Current use of MOUD
  8. Is comfortable speaking and reading English
  9. Has an existing Facebook account or willing to set one up
  10. Is willing and able to participate in the Facebook intervention for 3 months
  11. Has access to broadband internet on a mobile phone/computer/tablet at any location
  12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit.
  13. Provides written

Exclusion criteria

Exclusion Criteria:

  1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale
  2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Wiidookaage'win Facebook Group

    The Wiidookaage'win Facebook Group is an online, asynchronous group intervention that will run for 3-months with approximately 30 days of content developed. It is private and hidden, meaning only those in the study will be able to see or find the group. It will be moderated by two women from the study team (one AIAN and one biracial). A back-up moderator will also have access to the group. Participants will be able to comment, react, view, and post in the intervention group, and are encouraged to interact with one another.

    Behavioral: Wiidookaage'win Facebook Group

  • No intervention
    Online Resources Landing Page

    The Online Resources Landing Page was developed by the study team using https://carrd.co. It includes links to local programs in family services, substance use recovery, legal advocacy, etc. which already exist and may help support their recovery.

Interventions

  • BehavioralWiidookaage'win Facebook Group

    An online social media group program that incorporates social support, mindfulness-based, and cultural practices that may support OUD recovery.

06

What researchers measure

Primary outcomes

  1. Feasibility of Facebook Intervention

    The study team will measure the feasibility from the combined reports of recruitment, study retention, level of Facebook intervention uptake/engagement, and treatment satisfaction.

    Time frame: 3 months

Secondary outcomes

  1. Timeline Follow-back Interview and UDS to measure Opioid Abstinence

    The study team will explore the preliminary differential impact of the intervention compared with the control condition on opioid abstinence and MOUD continuation. Opioid and other substance use will be assessed through monthly Timeline Follow-Back (TLFB) interviews (Sobell \& Sobell, 1992; Wray et al., 2016). At 1, 3, and 6-months, the study team will obtain a UDS that will be used along with the TLFB interviews to measure opioid abstinence.

    Time frame: 6 months

  2. Reporting MOUD continuation

    The study team will summarize MOUD continuation as the proportion of participants reporting current use at 6-month follow-up.

    Time frame: 6 months

Other outcomes

  1. Perceived Stress Scale and Communal Mastery Scale

    The study team will explore the differential impact of the intervention compared with the control condition on constructs targeted by our intervention, specifically perceived stress and coping with stressful life circumstances from a more collectivist orientation, respectively.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2023 to primary completion in Oct 2026, 35 months.

Of 465 non-industry interventional studies with no phase under Opioid-Related Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 47. This study's 35 months is above that.

Counting every sponsor, half of 496 studies reached it within 29 months; a quarter within 13 and three quarters within 46.

Completion moved once since we started tracking on Sep 25, 2026: Oct 2026 → Oct 2027, on Nov 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 1, 2023
First posted
Aug 16, 2023
StartActual
Oct 16, 2023
Primary completionActual
Oct 15, 2026
CompletionEst.
Oct 15, 2027was Oct 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 12, 2026→Oct 15, 2026 (actual)
Nov 3, 2026
Study completion
Oct 31, 2026→Oct 15, 2027
Nov 19, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Mayo Clinic · Rochester, United StatesContact •••2600→•••2600
across 2 updates, Nov 3, 2026 – Nov 19, 2026
Show all 2 updates
  1. Nov 19, 2026
    Study completion Oct 31, 2026→Oct 15, 2027
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Mayo Clinic · Rochester, United StatesContact •••2600→•••2600
    + 1 other change: verification date
  2. Nov 3, 2026
    Primary completion Oct 12, 2026→Oct 15, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Mayo Clinic · Rochester, United StatesContact •••2600→•••2600
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05995886
Lead sponsor
Mayo Clinic
Responsible party
Christi Patten (Professor of Psychology, Mayo Clinic) — Principal investigator
First posted
Aug 16, 2023
Start date
Oct 16, 2023
Primary completion
Oct 15, 2026
Completion
Oct 15, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Ashley Brown
Contact
wiidookaagewin@mayo.edu
1-833-880-2600
Christi A Patten, PhD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion